ASCLEPII INC. SELECTED AS FINALIST FOR 2024 SXSW PITCH
Asclepii to showcase Artemis in the Student category
Cleveland, OH — 01/19/2024 — Asclepii, a startup leading the next-generation of tissue engineering therapeutics for wound healing, was selected as a finalist in the Student category for the 15th annual SXSW Pitch (formerly SXSW Accelerator).
SXSW Pitch, presented by KPMG, is the marquee event of South by Southwest® (SXSW®) Conference & Festivals (March 8 - 16, 2024), where leading startups from around the world showcase some of the most impressive technology innovations to a panel of hand-picked judges and a live audience. Out of the 670 companies that applied to present at SXSW Pitch 2024, Asclepii was selected among the 45 finalists spanning nine separate categories.
The two-day event will be held the first weekend of SXSW Conference & Festivals, Saturday, March 9 and Sunday, March 10, on the fourth floor of the Downtown Hilton Austin, Salon D/E. The event will then culminate with the 2024 SXSW Pitch Awards Ceremony on Sunday evening, March 10, where winning startups from each category and a Best in Show winner will be announced and honored in Salon H on the sixth floor of the Hilton Hotel.
SXSW Pitch will feature finalists across the following nine categories: Artificial Intelligence, Robotics & Voice, Enterprise & Smart Data, Entertainment, Media & Content, Extended Reality and Web3, Food, Nutrition & Health, Future of Work, Innovative World Technologies, Smart Cities, Transportation & Logistics and Student Startup.
Asclepii will present among four other companies in the Student category on March 10th.
"Having started this project at such an early age, it is an honor to be selected for such a prestigious award. I hopes this serves as the stepping stone for many more young innovators to take the leap into creating disruptive innovation. It is truly by standing on the shoulders of giants that we have got so far. I can't wait to see what the future holds!" said Franco Kraiselburd, CEO & Founder
Learn more at PR Newswire